Medical Innovation Exchange

Eloxx stock slumps lower on failed phase 2 cystic fibrosis trial

https://www.fiercebiotech.com/biotech/eloxx-stock-limbos-lower-failed-phase-2-cystic-fibrosis-trial

Leave a Comment

Your email address will not be published.

Leave the field below empty!